Phreesia (STU:19P) Cash And Cash Equivalents : €80.3 Mil (As of Jan. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Phreesia Cash And Cash Equivalents?

Phreesia's quarterly cash and cash equivalents declined from Jul. 2023 (€115.42 Mil) to Oct. 2023 (€97.89 Mil) but then stayed the same from Oct. 2023 (€97.89 Mil) to Jan. 2024 (€80.34 Mil).

Phreesia's annual cash and cash equivalents declined from Jan. 2022 (€277.41 Mil) to Jan. 2023 (€163.96 Mil) and declined from Jan. 2023 (€163.96 Mil) to Jan. 2024 (€80.34 Mil).

Phreesia Cash And Cash Equivalents Historical Data

The historical data trend for Phreesia's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Phreesia Cash And Cash Equivalents Chart

Phreesia Annual Data

Trend

Jan18

Jan19

Jan20

Jan21

Jan22

Jan23

Jan24

Cash And Cash Equivalents

Get a 7-Day Free Trial

81.37

179.62

277.41

163.96

80.34

Phreesia Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Cash And Cash Equivalents	Get a 7-Day Free Trial															163.96	136.59	115.42	97.89	80.34

Phreesia Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Phreesia (STU:19P) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Phreesia Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Phreesia's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Phreesia (STU:19P) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Phreesia Inc (STU:19P) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

PHR:USA 19P:Germany

Address

1521 Concord Pike, Suite 301 PMB 221, Wilmington, DE, USA, 19803

Website

https://www.phreesia.com

Phreesia Inc is a provider of comprehensive software solutions that improves the operational and financial performance of healthcare organizations by activating patients in their care to optimize patient health outcomes. Through its SaaS-based technology platform, it offers healthcare services clients a robust suite of integrated solutions that manage patient access, registration, payments, and clinical support. The Phreesia Platform encompasses a comprehensive range of technologies and services, including, but not limited to, initial patient contact, registration, appointment scheduling, payments, and post-appointment patient surveys.

Phreesia (STU:19P) Headlines

No Headlines